Gudibanda Nagaraja Bhuvana, Sai Mahima Umesh, Ramya Raghavan
{"title":"Expanding the frontiers of Schistosomiasis Treatment: The promise of Nanoparticle-Based Therapies.","authors":"Gudibanda Nagaraja Bhuvana, Sai Mahima Umesh, Ramya Raghavan","doi":"10.4103/jvbd.jvbd_180_23","DOIUrl":null,"url":null,"abstract":"<p><p>Schistosomiasis is one of the most overlooked parasitic diseases worldwide. The new roadmap for neglected tropical diseases (2021-2030), adopted by the World Health Assembly, sets global goals for combating these diseases. eliminating Schistosomiasis. Current treatment options for Schistosomiasis, such as Praziquantel, are limited. Nanoparticle-based treatments and vaccines have shown promise in overcoming the limitations of Praziquantel therapy by offering targeted and sustained drug delivery. We advocate prioritizing and enhancing funding and collaboration for nanoparticle research targeting Schistosomiasis. By investing in these innovative solutions in regions most impacted by Schistosomiasis, we have the potential to alleviate the treatment burden and enhance patient adherence. This review paper explores nanotechnological solutions, current trends, and long-term outcomes.</p>","PeriodicalId":17660,"journal":{"name":"Journal of Vector Borne Diseases","volume":" ","pages":""},"PeriodicalIF":1.2000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Vector Borne Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4103/jvbd.jvbd_180_23","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Schistosomiasis is one of the most overlooked parasitic diseases worldwide. The new roadmap for neglected tropical diseases (2021-2030), adopted by the World Health Assembly, sets global goals for combating these diseases. eliminating Schistosomiasis. Current treatment options for Schistosomiasis, such as Praziquantel, are limited. Nanoparticle-based treatments and vaccines have shown promise in overcoming the limitations of Praziquantel therapy by offering targeted and sustained drug delivery. We advocate prioritizing and enhancing funding and collaboration for nanoparticle research targeting Schistosomiasis. By investing in these innovative solutions in regions most impacted by Schistosomiasis, we have the potential to alleviate the treatment burden and enhance patient adherence. This review paper explores nanotechnological solutions, current trends, and long-term outcomes.
期刊介绍：
National Institute of Malaria Research on behalf of Indian Council of Medical Research (ICMR) publishes the Journal of Vector Borne Diseases. This Journal was earlier published as the Indian Journal of Malariology, a peer reviewed and open access biomedical journal in the field of vector borne diseases. The Journal publishes review articles, original research articles, short research communications, case reports of prime importance, letters to the editor in the field of vector borne diseases and their control.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
